« PreviousNext »International Journal of Radiation Oncology * Biology * Physics
Volume 51, Issue 3 , Pages 605-613, 1 November 2001
Volume 51, Issue 3 , Pages 605-613, 1 November 2001
Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer—A preliminary report☆
To access this article, please choose from the options below
☆ This work was supported by a Specialized Program of Research Excellence (SPORE) grant (CA58204) from the National Cancer Institute, the Methodist Hospital Foundation, the General Clinical Research Center (GCRC), Advantagene, Glaxo-Welcome, and Schering Oncology.
PII: S0360-3016(01)01692-3
doi:10.1016/S0360-3016(01)01692-3
© 2001 Elsevier Science Inc. All rights reserved.
« PreviousNext »International Journal of Radiation Oncology * Biology * Physics
Volume 51, Issue 3 , Pages 605-613, 1 November 2001
Volume 51, Issue 3 , Pages 605-613, 1 November 2001
